The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated efficacy and safety of KEYNOTE-224: A phase II study of pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC).
 
Masatoshi Kudo
Honoraria - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; MSD; MSD; MSD; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; MSD; MSD; MSD; MSD; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); EA Pharma (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Otsuka (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst); Takeda (Inst)
 
Richard S. Finn
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Pfizer
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst); Roche/Genentech (Inst)
Expert Testimony - Novartis; Novartis; Novartis; Novartis
 
Julien Edeline
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; BTG; BTG; BTG; BTG; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; MSD; MSD; MSD; MSD
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Roche; Roche; Roche; Roche
 
Stéphane Cattan
Leadership - Ipsen; Ipsen; Ipsen; Ipsen
Honoraria - Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen
Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen
Travel, Accommodations, Expenses - Ipsen; Ipsen; Ipsen; Ipsen
 
Sadahisa Ogasawara
Honoraria - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; Lilly; Lilly; Lilly; Lilly
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Eisai; Eisai; Eisai; Eisai; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Research Funding - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai
 
Daniel H. Palmer
Honoraria - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Nucana; Nucana; Nucana; Nucana
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Nucana; Nucana; Nucana; Nucana
Research Funding - Bayer; Bayer; Bayer; Bayer; Nucana; Nucana; Nucana; Nucana
 
Chris Verslype
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen; Novartis; Novartis; Novartis; Novartis; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Speakers' Bureau - BAYER; BAYER; BAYER; BAYER; Sirtex Medical; Sirtex Medical; Sirtex Medical; Sirtex Medical
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen
 
Vittorina Zagonel
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Janssen; Janssen; Janssen; Janssen; Pfizer; Pfizer; Pfizer; Pfizer; Roche; Roche; Roche; Roche
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Roche; Roche; Roche; Roche
 
Laetitia Fartoux
No Relationships to Disclose
 
Arndt Vogel
Honoraria - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Delcath Systems; Delcath Systems; Delcath Systems; Delcath Systems; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Baxalta; Baxalta; Baxalta; Baxalta; Bayer; Bayer; Bayer; Bayer; Delcath Systems; Delcath Systems; Delcath Systems; Delcath Systems; Lilly; Lilly; Lilly; Lilly; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche
Research Funding - Novartis; Novartis; Novartis; Novartis
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen; Roche; Roche; Roche; Roche
 
Debashis Sarker
Honoraria - Bayer; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Ipsen; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer (I); Pfizer (I); Pfizer (I); Pfizer (I)
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai; Eisai (I); Eisai (I); Eisai (I); Eisai (I); Ipsen (I); Ipsen (I); Ipsen (I); Ipsen (I); Novartis; Novartis; Novartis; Novartis
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; ipsen; ipsen; ipsen; ipsen; MiNA Therapeutics; MiNA Therapeutics; MiNA Therapeutics; MiNA Therapeutics
 
Gontran Verset
Consulting or Advisory Role - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); BTG (Inst); BTG (Inst); BTG (Inst); BTG (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); Eisai (Inst); TERUMO (Inst); TERUMO (Inst); TERUMO (Inst); TERUMO (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Ipsen; Ipsen; Ipsen; Ipsen
 
Stephen Lam Chan
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Novartis; Novartis; Novartis; Novartis
 
Jennifer J. Knox
Honoraria - Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck
 
Bruno Daniele
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; Ipsen; Ipsen; Ipsen; Ipsen; Lilly; Lilly; Lilly; Lilly; MSD; MSD; MSD; MSD
Consulting or Advisory Role - Eisai; Eisai; Eisai; Eisai; Incyte; Incyte; Incyte; Incyte; Ipsen; Ipsen; Ipsen; Ipsen; MSD; MSD; MSD; MSD; Sanofi; Sanofi; Sanofi; Sanofi
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Sanofi; Sanofi; Sanofi; Sanofi
 
Ellen B Gurary
Employment - Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
 
Abby B. Siegel
Employment - Merck; Merck; Merck; Merck
Stock and Other Ownership Interests - Merck; Merck; Merck; Merck
 
Lokesh Jain
Employment - Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
 
Ann-Lii Cheng
Honoraria - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer Yakuhin; Bayer Yakuhin; Bayer Yakuhin; Bayer Yakuhin; Eisai; Eisai; Eisai; Eisai; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Lilly; Lilly; Lilly; Lilly
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; Bayer Schering Pharma; BeiGene; BeiGene; BeiGene; BeiGene; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; CSR Pharma; CSR Pharma; CSR Pharma; CSR Pharma; Eisai; Eisai; Eisai; Eisai; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; IQVIA; IQVIA; IQVIA; IQVIA; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical; Ono Pharmaceutical
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst)